Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. Breastfeeding

Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. is safe in breast-feeding or not.

What is Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. used for?


Oseltamivir phosphate for oral suspension is an influenza neuraminidase inhibitor (NAI) indicated for: Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. (1.1) Prophylaxis of influenza A and B in patients 1 year and older. (1.2) Limitations of Use: Not a substitute for annual influenza vaccination. (1.3) Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. (1.3) Not recommended for patients with end-stage renal disease not undergoing dialysis. (1.3) 1.1 Treatment of Influenza Oseltamivir phosphate for oral suspension is indicated for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. 1.2 Prophylaxis of Influenza Oseltamivir phosphate for oral suspension is indicated for the prophylaxis of influenza A and B in patients 1 year and older. 1.3 Limitations of Use Oseltamivir phosphate for oral suspension is not a substitute for early influenza vaccination on an annual basis as recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. Influenza viruses change over time. Emergence of resistance substitutions could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use oseltamivir phosphate for oral suspension [see Microbiology (12.4)] . Oseltamivir phosphate for oral suspension is not recommended for patients with end-stage renal disease not undergoing dialysis [see DOSAGE AND ADMINISTRATION (2.4) and USE IN SPECIFIC POPULATIONS (8.6)] .

Is using Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. safe for breastfeeding
As per our analysis Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. contains only one ingredient and that is Oseltamivir acid. We have analyzed Oseltamivir acid and it seems to be safe to use Oseltamivir acid while breastfeeding, that means usage of Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. shall be safe while breastfeeding. Below you can check more details of Oseltamivir acid usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
8.2 Lactation Risk Summary Based on limited published data, oseltamivir and oseltamivir carboxylate have been shown to be present in human milk at low levels considered unlikely to lead to toxicity in the breastfed infant. Postmarketing experience has not reported any information to suggest serious adverse effects of oseltamivir exposure via breast milk in infants. It is not known if oseltamivir affects human milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for oseltamivir phosphate and any potential adverse effects on the breastfed child from the drug or from the underlying maternal condition.

Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. Breastfeeding Analsys


Oseltamivir acid while Breastfeeding

Safe

CAS Number: 204255-11-8

Prophylaxis and treament of Influenza virus disease. Excreted in non-significant levels into breast milk. No adverse effects have been shown in breastfed infants.


Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. Breastfeeding Analsys - 2


Oseltamivir acid while Breastfeeding

CAS Number: 196618-13-0

Limited data indicate that oseltamivir and its active metabolite are poorly excreted into breastmilk. Maternal dosages of 150 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Infants over 1 year of age can receive oseltamivir directly in doses much larger than those in breastmilk.


Is Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. safe while breastfeeding

I am nursing mother and I have already used Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc., what should I do?

Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.


My health care provider has asked me to use Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc., what to do?

Definitely, Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc., will my baby need extra monitoring?

No extra baby monitoring required while mother is using Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc.


Who can I talk to if I have questions about usage of Oseltamivir Phosphate | Lupin Pharmaceuticals, Inc. in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week